Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; MNEXSPIKE (COVID-19 Vaccine, mRNA)
The Food and Drug Administration (FDA) is announcing the issuance of approval of a product redeeming a priority review voucher. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to...
Sign up to read the full analysisDocument type: Notice. Agency: Health and Human Services Department, Food and Drug Administration. Published: 2026-04-16.
Why this matters to food and beverage teams
This notice is worth screening if your team tracks health and human services department, food and drug administration activity that could affect ingredients, labeling, plant operations, imports, or compliance timing.
Federal Register items are often early signals. Even when they look procedural, they can affect comment windows, effective dates, or how suppliers and plants plan around upcoming changes.
Track this document and its deadlines
Get the full analysis, comment period alerts, and compliance calendar -- free for F&B professionals.
Sign Up Free